期刊文献+

常染色体隐性多囊肾的研究进展 被引量:1

Research progress on the Autosomal recessive polycystic kidney disease
下载PDF
导出
摘要 常染色体隐性多囊肾病(ARPKD)是以肾小管囊肿(集合管系统为主)形成为特征,最终导致终末期肾病。ARPKD是由多囊肾肝疾病1(PKHD1)基因或DAZ相互作用蛋白1样基因(DZIP1L)突变引起。本课题组计划在外显子组测序的基础上进行全转录组测序,希望通过全转录组测序提高常染色体隐性遗传多囊性肾脏疾病的整体诊断率,并希望通过与数据库中的表达谱进行结果比对分析,进一步鉴定出新的致病变异,利用分析框架集中发掘患者独特的转录水平变化。本文主要对ARPKD突变基因、相关基因测序进展、临床表现及治疗进行综述。 Autosomal recessive polycystic kidney disease(ARPKD)is characterized by the formation of tubular cysts(mainly collecting duct system)that eventually lead to end-stage renal disease.At present,related researches have shown that the pathogenesis of ARPKD is mainly related to the mutation of PKHD1 gene and DZIP1L gene.Our team will conduct RNA-seq on the basis of the whole transcriptome sequencing in order to improve the diagnostic rate of ARPKD,and identify the new pathogenic mutations by comparing spectrum analysis results with the database of expression.In addition,we hope to further idetify new pathogenic mutations and to discover unique transcription level of patients by using the analysis framework.This article reviews mainly the mutant gene of ARPKD,related gene sequencing,clinical manifestations and treatment of ARPKD.
作者 刘洋 梁磊 赵建荣 LIU Yang;LIANG Lie;ZHAO Jianrong(Department of Nephrology,Affiliated Hospital of Inner Mongolia Medical University,Inner Mongolia,Hohhot 010010,China;不详)
出处 《河北医药》 CAS 2020年第21期3330-3334,共5页 Hebei Medical Journal
基金 国家自然科学基金项目(编号:81960130)。
关键词 常染色体隐性多囊肾 多囊肾肝疾病1 DAZ相互作用蛋白1样基因 基因测序 临床表现 治疗 autosomal recessive polycystic kidney disease polycystic liver kidney diseases DAZ interaction 1 like gene gene sequencing clinical manifestations treatment
  • 相关文献

参考文献1

二级参考文献10

  • 1Gunay A M, Avner E D, Bacallao R L, et al. Autosomal recessive polycystic kidney disease and congenital hepatic fibrosis:Summary statement of a first National Institutes of Health/Office of Rare Diseases conference [ J ]. J Pediatr,2006,149 (2) : 159-164.
  • 2Adeva M, El-Youssef M, Rossetti S, et al. Clinical and molecular characterization defines a broadened spectrum of autosomal recessive polycystic kidney disease ( ARPKD ) [ J ]. Medicine ( Baltimore ), 2006,85 ( 1 ) : 1-21.
  • 3Jang D G, Chae H, Shin J C, et al. Prenatal diagnosis of autosomal recessive polycystic kidney disease by molecular genetic analysis [ J ]. J Obstet Gynaecol Res ,2011,37 ( 11 ) : 1744-1747.
  • 4Dell K M. The spectrum of polycystic kidney disease in children[J]. Adv Chronic Kidney Dis,2011,18 (5) : 339-347.
  • 5Sinha A, Bagga A, Krishna A, et al. Revised guidelines on management of antenatal hydronephrosis[J]. Indian J Nephrol,2013, 92(9): 83-97.
  • 6Klaassen I, Neuhaus T J, Muller W D E. Antenatal oligohydramnios of renal origin:long term outcome [ J ]. Nephrol Dial Transplant,2007, 22:432-439.
  • 7Mehler K, Beck B B, Kaul I, et al. Respiratory and general outcome in neonates with renal oligohydramnios-a single-centre experience [J]. Nephrol Dial Transplant,2011,26( 11 ) :3514-3522.
  • 8Nagano J, Kitamura K, Hujer K M, et al. Fibrocystin interacts with CAML, a protein involved in Ca^2+ signaling[ J]. Biochem Biophys Res Commun .2005,338 (2) : 880-889.
  • 9Funl L, Onuchic L F, Gharavi A, et al. Milder presentation of recessive polycystic kidney disease requires presence of amino acid substitution mutations[ J]. J Am Soe Nephro1,2003,14 ( 8 ) :2004-2014.
  • 10Bergmann C, yon Bothmer J, Ortiz Brtiehle N, et al. Mutations in multiple PKD genes may explain early and severe polycystic kidneydisease[ J]. J Am Soc Nephrol,2011,22 ( 11 ) :2047-2056.

共引文献3

同被引文献1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部